PMID: 8978228Dec 14, 1996Paper

Point prevalence of mental disorder in unconvicted male prisoners in England and Wales

BMJ : British Medical Journal
D BrookeA Maden

Abstract

To determine prevalence of mental disorder among male unconvicted prisoners and to assess the treatment needs of this population. Semi-structured interview and case note review of randomly selected cross section of male remand population. Non-attenders were replaced by the next name on prison roll. Three young offenders' institutions and 13 adult men's prisons. 750 prisoners, representing 9.4% cross sectional sample of male unconvicted population. Prevalence of ICD-10 diagnoses of mental disorder, and associated treatment needs. Psychiatric disorder was diagnosed in 469 (63%) inmates. The main diagnoses were: substance misuse, 285 (38%); neurotic illness, 192 (26%); personality disorder, 84 (11%); psychosis, 36 (5%); other and uncertain, 36 (0.5%). Subjects could have more than one diagnosis. The average refusal rate was 18%. In total 414 inmates (55%) were judged to have an immediate treatment need: transfer to an NHS bed, 64 (9%); treatment by prison health care services, 131 (17%); motivational interviewing for substance misuse, 115 (15%); and therapeutic community placement, 104 (14%). Mental disorder was common among male unconvicted prisoners. Psychosis was present at four or five times the level found in the general popu...Continue Reading

References

Oct 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·P Bowden
Aug 10, 1991·BMJ : British Medical Journal·J GunnM Swinton
Jan 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·E Dooley
Jul 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·T Harding, E Zimmermann
Jan 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·G RobertsonA Grounds

❮ Previous
Next ❯

Citations

Apr 2, 2013·Social Psychiatry and Psychiatric Epidemiology·David J VinkersThomas Rinne
Jan 6, 2001·International Journal of Law and Psychiatry·P M Brinded
Mar 14, 2001·Journal of Affective Disorders·J BaillargeonJ Pulvino
Jun 22, 2012·Psychological Medicine·H StevensP B Mortensen
Oct 23, 2002·Health & Social Care in the Community·Jenny Secker, Kathryn Hill
Apr 28, 2006·Current Opinion in Psychiatry·Johann Brink
Dec 14, 1996·BMJ : British Medical Journal·D Chiswick
Sep 25, 1999·BMJ : British Medical Journal·L Birmingham
Aug 30, 2003·BMJ : British Medical Journal·Jo NurseJim Ormsby
Jun 9, 2006·BMC Psychiatry·Ellen KjelsbergTom-Gunnar Vik
Jan 6, 2007·Substance Abuse Treatment, Prevention, and Policy·Michael LukasiewiczIsabelle Gasquet
Feb 20, 2014·PloS One·Sergio Baxter AndreoliJair de Jesus Mari
Apr 11, 2014·Iranian Red Crescent Medical Journal·Zahra SepehrmaneshRezvan Saei
Jan 25, 2014·Indian Journal of Psychiatry·Vinod Kumar, Usha Daria
May 22, 2013·International Journal of Law and Psychiatry·Brant E FriesJohn P Hirdes
Mar 13, 2015·International Journal of Prisoner Health·Andrew ForresterPiyal Sen
Jan 5, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Lamiece HassanJenny Shaw
Feb 15, 2013·BMC Psychiatry·Daniel W C Kinyanjui, Lukoye Atwoli
May 3, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Seena Fazel, Katharina Seewald
Jun 8, 2002·Journal of the American Academy of Nurse Practitioners·Kathryn R Puskar, Lisa Bernardo
Jan 1, 2016·International Journal of Mental Health Systems·Berihun Assefa DachewTelake Azale Bisetegn
Jul 27, 2010·International Journal of Law and Psychiatry·David V James
Feb 28, 2016·Research in Developmental Disabilities·Afia AliAngela Hassiotis
Feb 25, 2009·International Journal of Law and Psychiatry·Massimiliano PiselliKaren M Abram
Feb 10, 2009·International Journal of Law and Psychiatry·Bernice S Elger
Feb 10, 2009·International Journal of Law and Psychiatry·Ketrina A SlyChristopher J Bench
Sep 19, 2008·International Journal of Law and Psychiatry·R ZoccaliM Meduri
Jul 23, 2008·International Journal of Law and Psychiatry·Seena FazelJohn Powell
Jun 22, 2005·Journal of Intellectual Disability Research : JIDR·J Cockram
Feb 12, 2009·Journal of Intellectual Disability Research : JIDR·V Herrington
Jun 19, 2015·Drug and Alcohol Review·Louisa DegenhardtGeorge Patton
Feb 9, 2007·Sociology of Health & Illness·Nick de Viggiani
Jan 28, 2009·Criminal Behaviour and Mental Health : CBMH·Charlotte RennieJenny Shaw
Jun 28, 2011·Criminal Behaviour and Mental Health : CBMH·Enric VicensPilar Sarda
Feb 11, 2011·Journal of Forensic Sciences·Milena P PondéMilena S S Mendonça
Mar 29, 2014·International Journal of Clinical Practice·A BartlettS Patel
Nov 13, 2009·Criminal Behaviour and Mental Health : CBMH·Jeremy CoidSimone Ullrich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.